National Institute of Diabetes and Digestive and Kidney Diseases
Government
US federal NIH institute funding research and SBIR/STTR grants in diabetes, digestive diseases, kidney, liver, obesity, and metabolic diseases.
Bethesda, United States · 12+ investments
Pre-Seed
Seed
Early Stage
Biotech
Healthcare
Life Sciences
Medical Devices
biotechnology
diabetes
digestive disease
kidney disease
metabolic disease
- Headquarters
- Bethesda, United States
- Founded
- 1950
- Website
- niddk.nih.gov
- Total Investments
- 12
- Last Investment
- Jan 2024
- Geographic Focus
- United States
Investment Thesis
Funds early-stage biomedical innovation via SBIR/STTR programs targeting diabetes, digestive, kidney, liver, obesity, and urologic diseases; congressionally mandated 3.65% extramural allocation to small business programs.
National Institute of Diabetes and Digestive and Kidney Diseases is a Government firm based in Bethesda, United States. It has made 12 investments in Biotech and Healthcare.
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.